Pioneering Regenerative Medicine: Breakthrough in Hypoimmunogenic Universal iPS Cells via HLA-Type Gene Knockout
Scientists Engineer Hypoimmunogenic iPS Cells via CRISPR-Cas9 Table of Contents Scientists Engineer Hypoimmunogenic iPS Cells via CRISPR-Cas9 Engineered iPS Cells Exhibit Normal Pluripotency and Reduced HLA Expression Engineered iPS Cells: Maintaining Pluripotency HLA-Triple-KO iPS Cells Show Reduced immunogenicity and Enhanced Genomic Stability in Key Study Genomic Stability Assessment of HLA-Triple-KO iPS Cells Long-Term in Vitro … Read more
